Is dissection of the internerve tissue during axillary lymphadenectomy for breast cancer necessary?

European Journal of Surgical Oncology

Volumn 26, Issue 2, 2000, Pages 153-154

  Mostafa, A ^a   Mokbel, K ^a   Engledow, A ^a   Leris, A C A ^a   Choy, C ^a   Wells, C ^a   Carpenter, R ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Axillary; Breast cancer; Internerve

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CLINICAL ARTICLE; DISSECTION; HUMAN; HUMAN TISSUE; LYMPH NODE; LYMPHADENECTOMY; MEDICAL DECISION MAKING; METASTASIS; NERVE; NERVE INJURY; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 0034097172     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.1999.0760     Document Type: Article

References (5)

1. Haybittle JL, Blamey RW, Ellston CW et al. A prognostic index in primary breast cancer. Br J Cancer. 45:1982;361-366.
2. Fisher B, Bauer M, Wickerham DU et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer: An NSABP update. Cancer. 52:1983;1551-1557.
3. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. Lancet. 339:1992;1-15.
4. Overgaard M, Hansen PS, Overgaard J et al. Postoperative radiotherapy in high risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med. 337:1997;949-955.
5. Overgaard M, Jensen M, Overgaard J et al. Postoperative radiotherapy in high risk postmenopausal breast cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet. 353:1993;1641-1648.